Vaping Products Reporting Regulations
REGULATORY IMPACT ANALYSIS STATEMENT
(This statement is not part of the Regulations.)
In 2018, Parliament amended the Tobacco Act, the Canada Consumer Product Safety Act (CCPSA) and the Food and Drugs Act (FDA) to address the harms and potential benefits of vaping products. The amendments to the Tobacco Act included new provisions to regulate the manufacture, sale, labelling and promotion of vaping products, as well as a name change to the Tobacco and Vaping Products Act (TVPA).
The availability of information in the public domain about vaping products is limited. The vaping market is evolving rapidly with the constant introduction of new vaping product technologies and novel product characteristics. Health Canada needs to timely access a variety of data to better understand the impact of vaping product use on the health and safety of Canadians. More specifically, access to relevant information (especially information that is not publicly available) about the vaping product market and their contents is needed to inform the development of regulations in support of the purpose of the TVPA, which includes preventing vaping product use from leading to the use of tobacco products by young persons and non-users of tobacco products. Such data is also needed to help advance policies and programs that further the objectives of Canada’s Tobacco Strategy (CTS), including helping people who smoke to quit tobacco and protecting youth and non-users from nicotine addiction.
Health Canada – 2022-06-18.